⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMY News
Bristol-Myers Squibb Co.
Bristol Myers Squibb Showcases New Long-Term and Real-World Data From Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2025
businesswire.com
BMY
Bristol Myers Squibb Announces Cash Tender Offers to Purchase Certain Notes
businesswire.com
BMY
Bristol Myers Squibb Reports Third Quarter Financial Results for 2025
businesswire.com
BMY
Bristol Myers Squibb Presents Two Late-Breaking Presentations Demonstrating Sotyktu (deucravacitinib) Efficacy in Psoriatic Arthritis and Systemic Lupus Erythematosus
businesswire.com
BMY
Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb
accessnewswire.com
BMY
SystImmune, Inc. and Bristol Myers Squibb Announce First Global Phase I Results of Iza-bren, an EGFR x HER3 Bispecific Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors at ESMO 2025
prnewswire.com
BMY
insitro Extends Research Collaboration with Bristol Myers Squibb Leveraging insitro’s ChemML Discovery Platform
businesswire.com
BMY
Bristol Myers Squibb to Present Data at ESMO ® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types
businesswire.com
BMY
SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration
prnewswire.com
BMY
Bristol Myers Squibb and National Community Pharmacists Association Pilot Rural Heart Health Care Initiatives
accessnewswire.com
BMY